Clinical Trial

Fasciotens to Treat an Open Abdomen - a Prospective Cohort Study

Study acronym: Fasciotens
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 19, 2023 (before its estimated May 2026 completion). Its status may not reflect the trial's current state.
Summary
The open abdomen can occur as a result of various diseases. After infections of the abdomen, compartment syndromes or traumata, it is essential for survival (1). This condition of the open abdomen lasts from days to months. Within a very short time, the fascia and abdominal wall structures retract in such a way that direct abdominal closure is often impossible. In addition, there is a pronounced intraabdominal oedema, which additionally increases the space required by the abdominal organs. Therefore, it is clinically indispensable to increase the space of the intraabdominal organs in this life-threatening situation. After the laparotomy (opening of the abdomen) has been performed, it is therefore not closed. However, the natural traction on the abdominal wall, in particular on the fascia, the attached musculature as well as skin and subcutis, no longer exists in this situation. As a result, these structures retract over the period of the existing laparostoma. In the present study, the CE-certified medical device Fasciotens Abdomen will be used to prove the functionality of this device and the user feasibility. The basic principle of Fasciotens Abdomen is the ventrally directed pulling force on the two fascial edges via an external device with support on the thorax and pelvis. The possibility to apply a traction to the fascia from the moment of opening the abdomen without reducing the intraabdominal space is absolutely new and the rationale of this technique. The objective of this study is to prove the obvious prevention of fascial retraction through the Fasciotens Abdomen device.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2019-07-23; most recent amendment 2023-04-17.
Status change: Not Yet Recruiting → Recruiting 2019-08-06
Trial Details
NCT Number NCT04033614
Lead Sponsor RWTH Aachen University
Collaborators: Fasciotens GmbH
Conditions Abdominal Compartment Syndrome, Pancreatitis,Acute Necrotizing, Intraabdominal Hypertension, Peritonitis
Enrollment 15 participants
Start Date 2019-08-05
Primary Completion 2026-05 (estimated)
Study Completion 2026-08 (estimated)
Updated on ClinicalTrials.gov 2023-04-19